Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results and Highlights Recent Period Activities

[Business Wire] – Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2013, and more

View todays social media effects on ALNY

View the latest stocks trending across Twitter. Click to view dashboard

See who Alnylam is hiring next, click here to view